Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck & Co. divulges new hSTING agonists

June 26, 2020

FDA clears first clinical trial of M-5049 in patients with COVID-19 pneumonia

June 26, 2020

First patient dosed in phase II study of TD-0903 for the treatment of ALI caused by COVID-19

June 26, 2020

SCOHIA initiates phase II study of SCO-792 in diabetic kidney disease

June 26, 2020

IBI-327, a bispecific antibody targeting PD-L1 and OX40 for cancer immunotherapy

June 26, 2020

Onxeo reports preclinical data for its new generation molecule, OX-401

June 26, 2020

Interim data from phase II study of once-weekly setmelanotide formulation

June 26, 2020

FDA lifts partial clinical hold on lacutamab TELLOMAK study

June 26, 2020

Bispecific antibody MEDI-7526 stimulates CD40 and downregulates PD-L1

June 26, 2020

IND clearance for phase II study of HST-5040 for methylmalonic acidemia and propionic acidemia

June 26, 2020

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...